Previous 10 | Next 10 |
2023-11-27 14:00:00 ET Summary InMode Ltd. investors experienced a collapse in October 2023 as INMD fell to a three-year low. I assessed that buyers have returned in November, potentially helping INMD to form a pivotal long-term bottom. InMode's best-in-class profitability and...
2023-11-26 23:45:18 ET Summary InMode, known for laser technology in cosmetic applications, faces a blend of market opportunities and financial challenges. INMD's innovative products like Morpheus8 and Evolve drive demand, but geopolitical and economic factors contribute to stock ...
2023-11-08 02:25:00 ET Summary LRT Capital is a fundamental investment hedge fund. Our sole aim in crafting our investment program is to maximize long-term investment returns. October was a challenging month for the investment strategy, with long holdings declining sharply due to ...
2023-11-07 04:52:04 ET Summary InMode Ltd's share price fell by 25% in October due to the Israel-Hamas conflicts and lowered revenue guidance. The company operates in a niche market between plastic surgery and laser procedures, giving it a competitive advantage. InMode is well...
2023-11-06 10:01:49 ET More on iShares U.S. Medical Devices ETF: IHI: Nibbling Again On Attractive Healthcare Sector Valuation The FDA Crash - Are Regulations Killing The Bull Case For Medical Devices And IHI? FDA forms advisory committee to regulate digital health ...
2023-11-03 11:56:14 ET More on InMode InMode (INMD) Q3 2023 Earnings Call Transcript InMode: Overblown Reaction On Guidance, A Rare Valuation The InMode Rollercoaster: Navigating The Revenue Adjustment InMode stock rallies 12% amid operations update in Israel...
2023-11-02 12:38:05 ET InMode (INMD) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Miri Segal - Investor Relations Moshe Mizrahy - Chief Executive Officer and Chairman of Board of Directors Shakil Lakhani - President, North Ame...
2023-11-02 12:04:32 ET More on InMode InMode: Overblown Reaction On Guidance, A Rare Valuation The InMode Rollercoaster: Navigating The Revenue Adjustment InMode: Bullish Support Failed To Materialize InMode misses Q3 top and bottom line estimates; updates FY...
2023-11-02 07:09:04 ET More on InMode InMode: Overblown Reaction On Guidance, A Rare Valuation The InMode Rollercoaster: Navigating The Revenue Adjustment InMode: Bullish Support Failed To Materialize Biggest stock movers today: Beyond Meat, InMode, Tupperwar...
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
News, Short Squeeze, Breakout and More Instantly...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...